Holen Sie sich die Stockscreener-App
1.87
0.27%
-0.010
Schlusskurs vom Vortag:
$1.88
Offen:
$1.87
24-Stunden-Volumen:
46,182
Relative Volume:
0.20
Marktkapitalisierung:
$83.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-28.54M
KGV:
-2.9219
EPS:
-0.64
Netto-Cashflow:
$-22.72M
1W Leistung:
+0.27%
1M Leistung:
+8.38%
6M Leistung:
+7.45%
1J Leistung:
-64.89%
1-Tages-Spanne:
$1.87
$1.88
1-Wochen-Bereich:
$1.86
$1.88
52-Wochen-Spanne:
$1.40
$7.88
Essa Pharma Inc Stock (EPIX) Company Profile
Firmenname
Essa Pharma Inc
Sektor
Branche
Telefon
(778) 331-0962
Adresse
SUITE 720, VANCOUVER, BC
Vergleichen Sie EPIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
1.875 | 83.36M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.60 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.78 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.23 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.12 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
297.73 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-04 | Herabstufung | Jefferies | Buy → Hold |
| 2024-11-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-11-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-03-04 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-11-02 | Eingeleitet | Jefferies | Buy |
| 2019-10-25 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Essa Pharma Inc Aktie (EPIX) Neueste Nachrichten
Chart based analysis of ESSA Pharma Inc. trendsAI-Powered Stock Trend Movement Analysis - Newser
What makes ESSA Pharma Inc. stock price move sharplyEarnings Report Summary with Market Impact - Newser
Is ESSA Pharma Inc. stock overvalued or undervaluedFree Stock Watchlist For Fast Growth - jammulinksnews.com
Live market analysis of ESSA Pharma Inc.Value Investing Checklist with Entry Signals - Newser
What is the dividend policy of ESSA Pharma Inc. stockEntry Signal Watchlist With High Returns - jammulinksnews.com
Does ESSA Pharma Inc. stock perform well during market downturnsUnlock powerful stock screening techniques - jammulinksnews.com
Why is ESSA Pharma Inc. stock attracting strong analyst attentionOutstanding risk-reward balance - jammulinksnews.com
When is ESSA Pharma Inc. stock expected to show significant growthSignificant capital appreciation - jammulinksnews.com
Is it the right time to buy ESSA Pharma Inc. stockDiscover breakthrough stocks before the crowd - jammulinksnews.com
Is ESSA Pharma Inc. stock a good hedge against inflation200 Percent Profit Outlook - Newser
Is ESSA Pharma Inc. a growth stock or a value stockInvest in stocks with strong fundamentals - jammulinksnews.com
Why ESSA Pharma Inc. stock attracts strong analyst attentionExplosive Growth Potential - Newser
ESSA Pharma Inc. Stock Analysis and ForecastTremendous return on equity - PrintWeekIndia
What analysts say about ESSA Pharma Inc. stockRemarkably fast returns - PrintWeekIndia
Will ESSA Pharma Inc. stock benefit from interest rate changesMarket-leading growth rates - jammulinksnews.com
Class Action Filed Against ESSA Pharma Inc. (EPIX)March 25, 2025 Deadline to JoinContact The Gross Law Firm - MarketScreener
What drives ESSA Pharma Inc. stock priceBreakthrough profits - PrintWeekIndia
ESSA Pharma Seeks Court Approval for Cash Distribution Amid XenoTherapeutics Merger - The Globe and Mail
ESSA Pharma to be Acquired by XenoTherapeutics in All-Cash Deal - The Globe and Mail
ESSA Pharma to seek court approval for cash distribution to shareholders - Investing.com Australia
ESSA Pharma to seek court approval for cash distribution to shareholders By Investing.com - Investing.com Nigeria
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders - Barchart.com
Is ESSA Pharma Inc. a good long term investmentSky-high profits - Autocar Professional
ESSA Pharma to Be Acquired by XenoTherapeutics - Global Legal Chronicle
How ESSA Pharma Inc. stock performs during market volatilityFree Stock Market Trend Analysis - Newser
XenoTherapeutics to acquire ESSA Pharma in deal backed by XOMA Royalty - Canadian Lawyer Magazine
Finanzdaten der Essa Pharma Inc-Aktie (EPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.56%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):